feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra
Arphra/Issuer/LALPATHLAB.NS

LALPATHLAB.NS

Dr. Lal PathLabs Limited
HealthcareMedical - Diagnostics & ResearchININRCountry macro →
$1,561.00
Jun 02, 2026
AI Brief
Revenue · FY
$27.63B
Net income
$5.05B
FY 2026
EPS · diluted
$30.20
EBITDA
$7.83B

Explain this page

Arphra AI

Company profile

DB · companies + sec_company_profile + company_profiles

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.

Headquarters
Tower B, SAS Tower, Gurugram, 122001
IN
Phone
91 12 4301 6500
AI description
Arphra AI
Loading cached description…

Identifiers

  • SymbolLALPATHLAB.NS
  • Legal nameDr. Lal PathLabs Limited
  • CEOShankha Banerjee
  • SectorHealthcare
  • IndustryMedical - Diagnostics & Research
  • CountryIN
  • CurrencyINR
  • ExchangeNSE
  • IPO dateDec 23, 2015
  • CIK
  • ISININE600L01024
  • CUSIPY2R0AQ143
  • LEI
  • Employees4,099

Trading

DB · key_metrics_ttm
  • Market cap$262.09B
  • P/E (TTM)
  • P/B
  • EV / EBITDA
  • Dividend yield